search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants.

Abhijeet Pataskar ,
Julien Champagne ,
Remco Nagel ,
Juliana Kenski ,
Maarja Laos ,
Justine Michaux ,
Hui Song Pak ,
Onno B Bleijerveld ,
Kelly Mordente ,
Jasmine Montenegro Navarro ,
Naomi Blommaert ,
Morten M Nielsen ,
Domenica Lovecchio ,
Everett Stone ,
George Georgiou ,
Mark C de Gooijer ,
Olaf van Tellingen ,
Maarten Altelaar ,
Robbie P Joosten ,
Anastassis Perrakis ,
Johanna Olweus ,
Michal Bassani-Sternberg ,
Daniel S Peeper ,
Reuven Agami

Abstract

Activated T cells secrete interferon-γ, which triggers intracellular tryptophan shortage by upregulating the indoleamine 2,3-dioxygenase 1 (IDO1) enzyme1-4. Here we show that despite tryptophan depletion, in-frame protein synthesis continues across tryptophan codons. We identified tryptophan-to-phenylalanine codon reassignment (W>F) as the major event facilitating this process, and pinpointed tryptophanyl-tRNA synthetase (WARS1) as its source. We call these W>F peptides 'substitutants' to distinguish them from genetically encoded mutants. Using large-scale proteomics analyses, we demonstrate W>F substitutants to be highly abundant in multiple cancer types. W>F substitutants were enriched in tumours relative to matching adjacent normal tissues, and were associated with increased IDO1 expression, oncogenic signalling and the tumour-immune microenvironment. Functionally, W>F substitutants can impair protein activity, but also expand the landscape of antigens presented at the cell surface to activate T cell responses. Thus, substitutants are generated by an alternative decoding mechanism with potential effects on gene function and tumour immunoreactivity.

More about this publication

Nature

Volume 603
Issue nr. 7902
Pages 721-727
Publication date 01-03-2022

Full text links

Publisher website (DOI) 10.1038/s41586-022-04499-2
Europe PubMed Central 35264796
Pubmed 35264796

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.